Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells

Nature

Volumn 434, Issue 7037, 2005, Pages 1148-1152

  Li, Qingsheng ^a   Dua, Lijie ^a   Estes, Jacob D ^a   Ma, Zhong Min ^d   Rourke, Tracy ^d   Wang, Yichuan ^d   Reilly, Cavan ^b   Carlis, John ^c   Miller, Christopher J ^d,e   Haase, Ashley T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; IMMUNOLOGY; MOLECULAR STRUCTURE; PATHOLOGY; VIRUSES;

APOPTOPIC PATHWAYS; GUT-ASSOCIATED LYMPHATIC TISSUE (GALT); HUMAN IMMUNODIFICIENCY VIRUS-1 (HIV-1); SIMIAN IMMUNODEFICIENCY VIRUS (SIV);

DISEASES;

CD4 ANTIGEN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RNA;

MEDICINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LYMPH NODE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION; ANIMAL; CD4+ T LYMPHOCYTE; COLON; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IN SITU HYBRIDIZATION; MACACA; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; RABBIT FIBROMA VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; COLON; FAS LIGAND PROTEIN; FEMALE; IMMUNOLOGIC MEMORY; IN SITU HYBRIDIZATION; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 17844376742     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03513     Document Type: Article

References (26)

1. Mowat, A. M. & Viney, J. L. The anatomical basis of intestinal immunity. Immunol. Rev. 156, 145-166 (1997).
2. + T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998).
3. + T cell depletion and enteropathy in simian immunodeficiency virus infected rhesus macaques. Gastroenterology 116, 1115-1123 (1999).
4. Schneider, T. et al. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Gut 37, 524-529 (1995).
5. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004).
6. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004).
7. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003).
8. Clayton, F., Snow, G., Reka, S. & Kotler, D. P. Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin. Exp. Immunol. 107, 288-292 (1997).
9. Lim, S. G. et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin. Exp. Immunol. 92, 448-154 (1993).
10. Veazey, R. & Lackner, A. The mucosal immune system and HIV-1 infection. AIDS Rev. 5, 245-252 (2003).
11. + T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74, 57-64 (2000).
12. + T cells. Science 286, 1353-1357 (1999).
13. + T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl Acad. Sci. USA 101, 5640-5645 (2004).
14. Boirivant, M. et al. HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis. J. Clin. Immunol. 18, 39-47 (1998).
15. Boirivant, M. et al. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J. Clin. Invest. 98, 2616-2622 (1996).
16. De Maria, R. et al. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest. 97, 316-322 (1996).
17. Testi, R., Phillips, J. H. & Lanier, L. L. Constitutive expression of a phosphorylated activation antigen (Leu 23) by CD3 bright human thymocytes. J. Immunol. 141, 2557-2563 (1988).
18. Testi, R., Phillips, J. H. & Lanier, L. L. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. J. Immunol. 142, 1854-1860 (1989).
19. Phillips, A. N. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271, 497-499 (1996).
20. Reilly, C. S. et al. The clustering of SIV infected cells in lymphatic tissue. J. Am. Stat. Assoc. 97, 943-954 (2002).
21. Mothe, B. R. et al. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J. Virol. 76, 875-884 (2002).
22. + lymphocyte response to major immunodominant epitopes after vaginal exposure to SIV; too late and too little. J. Virol (in the press).
23. Pope, M. & Haase, A. T. Transmission, acute HIV-1 infection and the quest for effective vaccines, microbicides and other strategies to prevent infection. Nature Med. 9, 847-852 (2003).
24. Miller, C. J. et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68, 6391-6400 (1994).
25. Poppema, S., Lai, R. & Visser, L. Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity. Am. J. Pathol. 139, 725-729 (1991).
26. Miller, C. J. et al. Propagation, and dissemination of infection after vaginal transmission of SIV. J. Virol (submitted).